Studies have shown that active fund managers routinely underperform the S&P500 index*​

InterCure Ltd. (NASDAQ: INCR)

INCR Stock Predictions and Ratings

WSX Rating:
SELL
WSX Forecast (1yr):
-5.10%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE

INCR Stock Analysis

INCR PE Ratio:

INCR PEG Ratio: Not Available

INCR Forward EPS Growth (12 month): 0.00%

INCR PS Ratio: 0.7

INCR PSG Ratio: Not Available

INCR Forward Revenue Growth (12 month): 0.00%

INCR Articles

No data was found